Safety Efficacy, and Cost-effectiveness of Modified Doses of Ready-to-use Therapeutic and Supplementary Foods for the Treatment of Moderate Acute Malnutrition Among Children 6-59 Months of Age in Ethiopia
Protocols for the community-based management of acute malnutrition (CMAM) have not changed significantly for more than 20 years, with relatively complex treatment protocols and persistent supply chain challenges that have limited overall program coverage, leaving millions of malnourished children without care annually. The overarching goal of this research project is to simultaneously test two novel simplified approaches in CMAM with potential to improve program coverage. The simplified approach includes two parallel clinical trials for SAM and MAM treatment. Two fixed-dose regimes of RUTF will be tested against the current fixed-dose regimen of RUSF for children with MAM.
• Age 6-59 months
• Reside in the catchment area of the health post where the trial is to be conducted without plans to leave the area over the next year
• Uncomplicated moderate acute malnutrition, as defined by no signs of severe illness that would require referral to inpatient facility
• Pass appetite test conducted at the time of enrollment
• Consent for randomization into the study given by mother, father, and/or other primary caregiver
• Mid-upper arm circumference of 115-124 mm without nutritional edema
• Weight-for-height Z-score (WHZ) between -2 and -3